Key Points
- Glenbrook Capital Management bought 15,000 Senestech shares at $1.30 each, increasing its position by 1.42% to 1,072,804 shares valued at approximately $1.39 million. The purchase was disclosed in an SEC filing.
- Senestech reported quarterly revenue of $0.77 million and an adjusted loss of $0.35 per share, beating analyst estimates, but remains deeply unprofitable with a negative net margin of 294.73%.
- Analyst sentiment remains negative: the stock has a consensus “Sell” rating, opened at $1.27, and trades well below its 12-month high of $5.35.
Senestech, Inc. (NASDAQ:SNES - Get Free Report) major shareholder Glenbrook Capital Management bought 15,000 shares of the business's stock in a transaction on Thursday, August 6th. The shares were acquired at an average cost of $1.30 per share, for a total transaction of $19,500.00. Following the transaction, the insider directly owned 1,072,804 shares in the company, valued at approximately $1,394,645.20. This trade represents a 1.42% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Large shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Friday, August 7th, Glenbrook Capital Management acquired 6,490 shares of Senestech stock. The shares were bought at an average cost of $1.30 per share, for a total transaction of $8,437.00.
- On Monday, July 20th, Glenbrook Capital Management bought 35,000 shares of Senestech stock. The stock was bought at an average price of $1.47 per share, for a total transaction of $51,450.00.
- On Tuesday, June 30th, Glenbrook Capital Management bought 35,000 shares of Senestech stock. The stock was bought at an average price of $1.51 per share, for a total transaction of $52,850.00.
- On Monday, June 22nd, Glenbrook Capital Management bought 5,000 shares of Senestech stock. The stock was purchased at an average price of $1.66 per share, with a total value of $8,300.00.
- On Wednesday, June 17th, Glenbrook Capital Management purchased 3,264 shares of Senestech stock. The shares were purchased at an average cost of $1.61 per share, with a total value of $5,255.04.
- On Monday, June 8th, Glenbrook Capital Management purchased 7,000 shares of Senestech stock. The stock was purchased at an average price of $1.61 per share, for a total transaction of $11,270.00.
- On Friday, June 5th, Glenbrook Capital Management purchased 13,159 shares of Senestech stock. The stock was purchased at an average price of $1.57 per share, for a total transaction of $20,659.63.
- On Thursday, June 4th, Glenbrook Capital Management acquired 8,230 shares of Senestech stock. The stock was purchased at an average cost of $1.65 per share, for a total transaction of $13,579.50.
- On Monday, May 18th, Glenbrook Capital Management acquired 10,000 shares of Senestech stock. The shares were purchased at an average price of $1.59 per share, with a total value of $15,900.00.
- On Friday, May 15th, Glenbrook Capital Management bought 7,120 shares of Senestech stock. The shares were purchased at an average cost of $1.65 per share, with a total value of $11,748.00.
Senestech Price Performance
Shares of SNES opened at $1.27 on Tuesday. The company has a market cap of $6.88 million, a price-to-earnings ratio of -0.93 and a beta of 0.28. Senestech, Inc. has a twelve month low of $1.15 and a twelve month high of $5.35. The company has a quick ratio of 5.81, a current ratio of 6.78 and a debt-to-equity ratio of 0.02. The company has a 50 day moving average of $1.50 and a two-hundred day moving average of $1.71.
Senestech (NASDAQ:SNES - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.37) by $0.02. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%.The business had revenue of $0.77 million for the quarter, compared to the consensus estimate of $0.60 million. As a group, analysts predict that Senestech, Inc. will post -1.57 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings raised Senestech from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, July 10th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Senestech has a consensus rating of "Sell".
Read Our Latest Analysis on SNES
Institutional Trading of Senestech
A number of hedge funds and other institutional investors have recently made changes to their positions in SNES. Geode Capital Management LLC purchased a new position in shares of Senestech during the second quarter worth $59,000. Jane Street Group LLC purchased a new stake in Senestech in the second quarter valued at $161,000. Millennium Management LLC purchased a new stake in Senestech in the third quarter valued at $126,000. Diversify Advisory Services LLC acquired a new stake in Senestech during the 4th quarter worth about $34,000. Finally, Renaissance Technologies LLC grew its position in Senestech by 35.2% during the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company's stock worth $306,000 after purchasing an additional 37,165 shares during the period. Institutional investors and hedge funds own 5.19% of the company's stock.
Senestech Company Profile
(
Get Free Report)
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company's core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company's flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
